What is BofA Securities's price target for CRL?

BofA Securities's latest stated price target for Charles River Laboratories International Inc. (CRL) is $225, from its action on Dec 15, 2025.

What is BofA Securities's rating on CRL?

BofA Securities rates CRL Buy, a bullish rating, as of Dec 15, 2025.

When did BofA Securities last change its view on CRL?

On Dec 15, 2025, BofA Securities upgrades to Buy from Neutral, price target $225.

Analyst firms · BofA Securities · CRL

BofA Securities CRL price target and rating history

Charles River Laboratories International Inc. (CRL) · Health Care

BofA Securities rates Charles River Laboratories International Inc. (CRL) Buy with a $225 price target, as of its latest action on Dec 15, 2025. It has published 3 rating actions on CRL since February 2022, including 1 upgrade and 1 downgrade. Across 5 firms with a CRL price target in the last 12 months, the median target is $220. BofA Securities's $225 is 2% above that.

Current rating: Buy
Price target: $225
Median target, all firms: $220
Actions on CRL: 3

BofA Securities price target on CRL

BofA Securities price target on CRL, each point a stated target, February 2022 to December 2025.

Every BofA Securities rating on CRL

Dec 15, 2025
UpgradeBofA Securities upgrades to Buy from Neutral, price target $225
Oct 2, 2024
DowngradeBofA Securities downgrades to Neutral from Buy, price target $250 to $215
Feb 17, 2022
ReiterateBofA Securities cuts its price target to $400 from $445, keeps Buy

How other firms rate CRL

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
UBS	Buy	$357	Sep 30, 2026
CLSA	Hold	$219	Jul 20, 2026
Morgan Stanley	Overweight	$220	Jun 17, 2026
RBC Capital Markets	Outperform	$215	Apr 14, 2026
BofA Securities	Buy	$225	Dec 15, 2025
Argus Research	Buy		Nov 17, 2025

Questions about BofA Securities and CRL

What is BofA Securities's price target for CRL?: BofA Securities's latest stated price target for Charles River Laboratories International Inc. (CRL) is $225, from its action on Dec 15, 2025.
What is BofA Securities's rating on CRL?: BofA Securities rates CRL Buy, a bullish rating, as of Dec 15, 2025.
When did BofA Securities last change its view on CRL?: On Dec 15, 2025, BofA Securities upgrades to Buy from Neutral, price target $225.
How does BofA Securities's CRL target compare with other analysts?: Across 5 firms with a CRL price target in the last 12 months, the median target is $220. BofA Securities's $225 is 2% above that.

More CRL rating histories

All BofA Securities ratings CRL news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.